Tamsulosin Hydrochloride Capsule
Product Images NDC 68071-4872

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 68071-4872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4872 9)

Label for Tamsulosin Hydrochloride 0.4 mg capsules by NuCare Pharmaceuticals, Inc., containing 90 capsules. The label includes information about the capsule appearance as oblong olive green opaque cap/orange opaque body, imprinted with 'CL 23' on the cap and '04' on the body. Manufactured by Macleods Pharmaceuticals Ltd. and packaged by NuCare Pharmaceuticals, Inc. Storage instructions and warnings are also provided.*

FDA Label Image

Fig (Tamsulosin Fig 1)

A line graph showing plasma concentration (ng/mL) over time (hours) comparing Tamsulosin Hydrochloride levels in fasted versus fed states. The fasted state line peaks higher and earlier than the fed state, illustrating the drug's plasma concentration profile up to 36 hours after administration.*

FDA Label Image

Fig (Tamsulosin Fig 2a)

This line graph depicts the mean change over time in a treatment study for Tamsulosin Hydrochloride capsules at 0.4 mg and 0.8 mg doses versus placebo. The x-axis shows the duration of treatment in weeks up to 13 weeks and LOCF, and the y-axis shows mean change. Data points represent the three groups' trends in mean change across the treatment period.*

FDA Label Image

Fig (Tamsulosin Fig 2b)

A line graph showing mean change over duration of treatment in weeks for Tamsulosin Hydrochloride at doses of 0.8 mg and 0.4 mg compared to placebo. The x-axis represents treatment duration from 0 to 13 weeks plus LOCF, and the y-axis shows mean change values. Three lines represent data trends for 0.8 mg, 0.4 mg, and placebo groups, with sample sizes noted at various time points.*

FDA Label Image

Fig (Tamsulosin Fig 3a)

A line graph depicting mean change in a variable (mL/sec) over a 13-week treatment period. Three groups are shown: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis represents treatment duration in weeks, and the y-axis shows mean change values. Data points include sample size at each timepoint for the groups.*

FDA Label Image

Fig (Tamsulosin Fig 3b)

A line graph showing mean change in a measurement (mL/sec) over treatment duration in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The graph includes data points connected by dashed and solid lines, with the 0.8 mg group showing the highest mean change, followed by the 0.4 mg and placebo groups over various time points.*

FDA Label Image

Str (Tamsulosin Str)

Chemical structure diagram of Tamsulosin Hydrochloride showing the molecular arrangement of atoms and functional groups typical for this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.